Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 15, 2025 08:10 ET | Source: Custom Market Insights

[Latest] Global Clinical Trial Outsourcing Market Size/Share Worth USD 91,210.1 Million by 2033 at a 7.46% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Clinical Trial Outsourcing Market Size, Trends and Insights By Services...
January 15, 2024 11:00 ET | Source: Emergen Research

Biopharmaceutical Market Size Worth USD 1651.4 Billion in 2032 | Emergen Research

Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global biopharmaceutical market size was USD 411.4 Billion in 2022 and is expected to register a rapid revenue CAGR of 15.2% during the forecast...
July 18, 2023 04:30 ET | Source: Custom Market Insights

[Latest] Global Women’s Health Diagnostics Market Size/Share Worth USD 45.4 Billion by 2032 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, July 18, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Women’s Health Diagnostics Market Size, Trends and Insights By Application...
May 24, 2022 10:39 ET | Source: STRATEGIC MARKET RESEARCH LLP

Human Microbiome Market is expected to foster up to a landmark of USD 1318.72 Million by 2030 with a CAGR value of around 31.08%.

New York, United States, May 24, 2022 (GLOBE NEWSWIRE) -- A Human Microbiome comprises archaea, viruses, bacteria, & eukaryotes which reside within & outside our body system. These organisms...
November 03, 2014 08:30 ET | Source: AIM ImmunoTech Inc.

Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Collaborate on Alferon(R) and Ampligen(R) Against the Ebola Virus

PHILADELPHIA, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has been informed by USAMRIID scientists that they have in-vitro data...
July 22, 2014 08:30 ET | Source: AIM ImmunoTech Inc.

Hemispherx Achieves High Ranking in Sensitivity Testing Against MERS/SARS Coronaviruses Compared to Other Drugs

PHILADELPHIA, July 22, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced that a new publication abstract in Infectious Disorder Drug Targets (2014 Jul 13. [Epub ahead of print])...